BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2819750)

  • 41. Usefulness of serum neopterin in renal transplantation considering the neopterin/creatinine ratio.
    Kaneda Y; Suga A
    Nephron; 1988; 49(3):259-60. PubMed ID: 3041297
    [No Abstract]   [Full Text] [Related]  

  • 42. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pancreatic juice neopterin excretion--reliable marker for detection of pancreatic allograft rejection.
    Königsrainer A; Reibnegger G; Ofner D; Klima G; Tauscher T; Margreiter R
    Transplant Proc; 1990 Apr; 22(2):671-2. PubMed ID: 1691547
    [No Abstract]   [Full Text] [Related]  

  • 44. [Differential diagnosis of transplant function disorders in therapy with monoclonal antibodies OKT3].
    Müller T; Keuchel M; Schindler S; Steinmetz A; Feiber H; Lange H
    Helv Chir Acta; 1991 Sep; 58(3):271-5. PubMed ID: 1769844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discriminating rejection from CMV infection in renal allograft recipients using flow cytometry.
    Siegel DL; Fox I; Dafoe DC; Power M; Asplund M; Zellers L; Barker CF; Prystowsky MB
    Clin Immunol Immunopathol; 1989 May; 51(2):157-71. PubMed ID: 2539282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
    Szymczakiewicz-Multanowska AM; Kuźniewski M; Zawilińska B; Zgórniak-Nowosielska I; Uracz D; Ignacak E; Betkowska-Prokop A; Sułowicz W
    Przegl Lek; 2001; 58(7-8):772-7. PubMed ID: 11769385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concentrations of neopterin in serum of recipients of renal allografts.
    Reibnegger G; Fuchs D; Hausen A; Werner ER; Werner-Felmayer G; Wachter H
    Clin Chem; 1989 Oct; 35(10):2157. PubMed ID: 2791299
    [No Abstract]   [Full Text] [Related]  

  • 48. Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases.
    Margreiter R; Fuchs D; Hausen A; Huber C; Reibnegger G; Spielberger M; Wachter H
    Transplantation; 1983 Dec; 36(6):650-3. PubMed ID: 6362141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporin A in renal transplantation: a prospective randomized trial.
    Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon-gamma, neopterin, and interleukin-2 receptor levels in the serum of kidney transplant recipients.
    Steiner G; Zlabinger G; Karamehic J; Pohanka E; Kovarik J; Woloszczuk W
    Transplant Proc; 1990 Aug; 22(4):1857-8. PubMed ID: 2117813
    [No Abstract]   [Full Text] [Related]  

  • 52. Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients.
    Magalini SC; Nanni G; Tacchino RM; Avolio AW; Castagneto M
    Transplant Proc; 1992 Dec; 24(6):2547-8. PubMed ID: 1465861
    [No Abstract]   [Full Text] [Related]  

  • 53. 'Nephrotoxicity' and metabolic acidosis in transplant patients on cyclosporin A.
    Hamilton DV; Evans DB; Henderson RG; Thiru S; Calne RY; White DJ; Carmichael DJ
    Proc Eur Dial Transplant Assoc; 1981; 18():400-9. PubMed ID: 7036160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue polypeptide specific antigen, neopterin, and CRP for monitoring heart transplant recipients.
    Vogl M; Andert SE; Müller MM
    Clin Biochem; 1995 Jun; 28(3):291-5. PubMed ID: 7554248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy.
    Guerin C; Pozzetto B; Genin C; Berthoux FC; Gaudin OG
    Nephrol Dial Transplant; 1988; 3(1):77-80. PubMed ID: 2837679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous determination of neopterin and creatinine in serum with solid-phase extraction and on-line elution liquid chromatography.
    Werner ER; Fuchs D; Hausen A; Reibnegger G; Wachter H
    Clin Chem; 1987 Nov; 33(11):2028-33. PubMed ID: 3119253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neopterin levels in long-term renal allograft recipients.
    König P; Margreiter R; Huber C; Fuchs D; Hausen A; Reibnegger G; Wachter H
    Immunobiology; 1985 Mar; 169(2):208-12. PubMed ID: 3888825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.
    Shah AP; Chen JM; Fridell JA
    Clin Transplant; 2015 Dec; 29(12):1221-9. PubMed ID: 26458498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.